Structural Modeling and Molecular Dynamics of the Immune Checkpoint Molecule HLA-G

被引:9
|
作者
Arns, Thais [1 ]
Antunes, Dinler A. [2 ]
Abella, Jayvee R. [2 ]
Rigo, Mauricio M. [2 ]
Kavraki, Lydia E. [2 ]
Giuliatti, Silvana [3 ]
Donadi, Eduardo A. [1 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Basic & Appl Immunol, Ribeirao Preto, Brazil
[2] Rice Univ, Dept Comp Sci, Houston, TX USA
[3] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, Brazil
来源
FRONTIERS IN IMMUNOLOGY | 2020年 / 11卷
关键词
HLA-G; HLA-G1 soluble dimer; HLA-G5; isoform; molecular dynamics; structural bioinformatics; CLASS-I; G EXPRESSION; INHIBITORY RECEPTOR; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; TUMOR-CELLS; WEB SERVER; ANTIGEN; COMPLEX; BINDING;
D O I
10.3389/fimmu.2020.575076
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HLA-G is considered to be an immune checkpoint molecule, a function that is closely linked to the structure and dynamics of the different HLA-G isoforms. Unfortunately, little is known about the structure and dynamics of these isoforms. For instance, there are only seven crystal structures of HLA-G molecules, being all related to a single isoform, and in some cases lacking important residues associated to the interaction with leukocyte receptors. In addition, they lack information on the dynamics of both membrane-bound HLA-G forms, and soluble forms. We took advantage of in silico strategies to disclose the dynamic behavior of selected HLA-G forms, including the membrane-bound HLA-G1 molecule, soluble HLA-G1 dimer, and HLA-G5 isoform. Both the membrane-bound HLA-G1 molecule and the soluble HLA-G1 dimer were quite stable. Residues involved in the interaction with ILT2 and ILT4 receptors (alpha 3 domain) were very close to the lipid bilayer in the complete HLA-G1 molecule, which might limit accessibility. On the other hand, these residues can be completely exposed in the soluble HLA-G1 dimer, due to the free rotation of the disulfide bridge (Cys42/Cys42). In fact, we speculate that this free rotation of each protomer (i.e., the chains composing the dimer) could enable alternative binding modes for ILT2/ILT4 receptors, which in turn could be associated with greater affinity of the soluble HLA-G1 dimer. Structural analysis of the HLA-G5 isoform demonstrated higher stability for the complex containing the peptide and coupled beta 2-microglobulin, while structures lacking such domains were significantly unstable. This study reports for the first time structural conformations for the HLA-G5 isoform and the dynamic behavior of HLA-G1 molecules under simulated biological conditions. All modeled structures were made available through GitHub (https://github.com/KavrakiLab/), enabling their use as templates for modeling other alleles and isoforms, as well as for other computational analyses to investigate key molecular interactions.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] The role of HLA-G molecule and HLA-G gene polymorphisms in tumors, viral hepatitis, and parasitic diseases
    Dias, Fabricio C.
    Castelli, Erick C.
    Collares, Cristhianna V. A.
    Moreau, Philippe
    Donadil, Eduardo A.
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [22] First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G
    Anna, Francois
    Bole-Richard, Elodie
    LeMaoult, Joel
    Escande, Marie
    Lecomte, Martin
    Certoux, Jean-Made
    Souque, Philippe
    Garnache, Francine
    Adotevi, Olivier
    Langlade-Demoyen, Pierre
    Loustau, Maria
    Caumartin, Julien
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (03)
  • [23] Effect of the HLA-G/ILT2 pathway as an immune system checkpoint in gastric cancer
    Vaquero-Yuste, Christian
    Aguilar Sopena, Oscar
    Lasa-Unzue, Inmaculada
    Lopez-Garcia, Adela
    Gomez-Sanz, Remedios
    Gutierrez-Calvo, Alberto
    Roda Navarro, Pedro
    Manuel Martin-Villa, Jose
    Juarez, Ignacio
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 737 - 737
  • [24] HLA-G and Immune Evasion in Cancer Cells
    Sheu, Jim
    Shih, Le-Ming
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (04) : 248 - 257
  • [25] Expression of HLA-G molecule in patients with oral cancer
    Goncalves, Andreia Souza
    Wastowski, Isabela Jube
    Capeletti, Lucas Raineri
    Goncalves Alencar, Rita de Cassia
    Silva, Tarcilia Aparecida
    Batista, Aline Carvalho
    TISSUE ANTIGENS, 2012, 80 (01): : 93 - 94
  • [26] The immunosuppressive molecule HLA-G and its clinical implications
    Gonzalez, Alvaro
    Rebmann, Vera
    LeMaoult, Joel
    Horn, Peter A.
    Carosella, Edgardo D.
    Alegre, Estibaliz
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2012, 49 (03) : 63 - 84
  • [27] Beyond the increasing complexity of the immunomodulatory HLA-G molecule
    Carosella, Edgardo D.
    Favier, Benoit
    Rouas-Freiss, Nathalie
    Moreau, Philippe
    LeMaoult, Joel
    BLOOD, 2008, 111 (10) : 4862 - 4870
  • [28] HLA-G: immunoregulatory molecule involved in allograft acceptance
    Creput, C
    Durrbach, A
    Charpentier, B
    Carosella, ED
    Rouas-Freiss, N
    NEPHROLOGIE, 2003, 24 (08): : 451 - 456
  • [29] HLA-G Expressing Immune Cells in Immune Mediated Diseases
    Contini, P.
    Murdaca, Giuseppe
    Puppo, Francesco
    Negrini, Simone
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [30] Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer
    Chen, Qiong-Yuan
    Zhou, Wen-Jun
    Zhang, Jiang-Gang
    Zhang, Xia
    Han, Qiu-Yue
    Lin, Aifen
    Yan, Wei-Hua
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 109